Metraipolis › archive › dc_dffec4546537

PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer — Europe PMC PMID:41491583

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41491583
DOI
10.1186/s40779-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-07T00:50:43.518Z
SHA-256 of the archived text
70ab3bf2b292fb1c9b570837d555293b82cefd8c7bbd63e950a2054c0a75804d
Stable URL of this page
https://metraipolis.com/documento/dc_dffec4546537

How to cite

PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer — Europe PMC PMID:41491583 — Europe PMC (en), https://europepmc.org/article/MED/41491583 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dffec4546537 (Metraipolis archive dc_dffec4546537, sha256 70ab3bf2b292fb1c9b570837d555293b82cefd8c7bbd63e950a2054c0a75804d)
BibTeX
@misc{dcdffec4546537,
  title = {PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer — Europe PMC PMID:41491583},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41491583},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dffec4546537; sha256 70ab3bf2b292fb1c9b570837d555293b82cefd8c7bbd63e950a2054c0a75804d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41491583. Agents can read the archived copy with the MCP tool read_document.